These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 28058850)
21. [Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma]. Gao H; Ou YL; Zhang KR; Zhang ZB; Wang WL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):42-7. PubMed ID: 17285543 [TBL] [Abstract][Full Text] [Related]
22. PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma. Pandey PR; Chatterjee B; Olanich ME; Khan J; Miettinen MM; Hewitt SM; Barr FG J Pathol; 2017 Apr; 241(5):626-637. PubMed ID: 28138962 [TBL] [Abstract][Full Text] [Related]
23. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma. Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785 [TBL] [Abstract][Full Text] [Related]
29. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382 [TBL] [Abstract][Full Text] [Related]
30. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. Ahn EH Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752 [TBL] [Abstract][Full Text] [Related]
31. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Yasuda T; Perry KD; Nelson M; Bui MM; Nasir A; Goldschmidt R; Gnepp DR; Bridge JA Hum Pathol; 2009 Mar; 40(3):341-8. PubMed ID: 18973919 [TBL] [Abstract][Full Text] [Related]
32. A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysis. Lynn M; Shah N; Conroy J; Ennis S; Morris T; Betts D; O'Sullivan M Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):213-21. PubMed ID: 24614150 [TBL] [Abstract][Full Text] [Related]
33. Uncovering metabolism in rhabdomyosarcoma. Monti E; Fanzani A Cell Cycle; 2016; 15(2):184-95. PubMed ID: 26209235 [TBL] [Abstract][Full Text] [Related]
34. Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group. Arnold MA; Anderson JR; Gastier-Foster JM; Barr FG; Skapek SX; Hawkins DS; Raney RB; Parham DM; Teot LA; Rudzinski ER; Walterhouse DO Pediatr Blood Cancer; 2016 Apr; 63(4):634-9. PubMed ID: 26756883 [TBL] [Abstract][Full Text] [Related]
35. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488 [TBL] [Abstract][Full Text] [Related]
36. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype. Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938 [TBL] [Abstract][Full Text] [Related]
37. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry. Dehner CA; Rudzinski ER; Davis JL Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061 [TBL] [Abstract][Full Text] [Related]
38. Update on molecular findings in rhabdomyosarcoma. El Demellawy D; McGowan-Jordan J; de Nanassy J; Chernetsova E; Nasr A Pathology; 2017 Apr; 49(3):238-246. PubMed ID: 28256213 [TBL] [Abstract][Full Text] [Related]
39. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Wachtel M; Dettling M; Koscielniak E; Stegmaier S; Treuner J; Simon-Klingenstein K; Bühlmann P; Niggli FK; Schäfer BW Cancer Res; 2004 Aug; 64(16):5539-45. PubMed ID: 15313887 [TBL] [Abstract][Full Text] [Related]
40. Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar Features. La Starza R; Nofrini V; Pierini T; Pierini V; Zin A; Bisogno G; Cerri C; Caniglia M; Sidoni A; Ludwig K; Mecucci C Pediatr Blood Cancer; 2015 Dec; 62(12):2238-41. PubMed ID: 26179572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]